MAIA — Maia Biotechnology Balance Sheet
0.000.00%
- $42.23m
- $32.09m
Annual balance sheet for Maia Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.663 | 10.6 | 11 | 7.15 | 9.6 |
| Net Total Receivables | — | — | 0.303 | 0.145 | 0.077 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.747 | 10.7 | 11.8 | 7.56 | 10.2 |
| Other Long Term Assets | |||||
| Total Assets | 0.747 | 11.3 | 12 | 7.57 | 10.2 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.69 | 2.15 | 3.27 | 4.94 | 3.83 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.08 | 2.15 | 3.51 | 7.09 | 6.52 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -3.34 | 9.18 | 8.51 | 0.478 | 3.63 |
| Total Liabilities & Shareholders' Equity | 0.747 | 11.3 | 12 | 7.57 | 10.2 |
| Total Common Shares Outstanding |